A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors

Clinical trial NCT04073680 · UNKNOWN

Trial details

NCT number: NCT04073680
Sponsor: Petra Pharma
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Endometrial Cancer Lung Cancer Colo-rectal Cancer Head and Neck Cancer

Start date: 2020-09-01
Primary completion: 2021-07-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.